Aurobindo Pharma Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aurobindo Pharma Ltd with three other
companies in this sector in India:
sales of 143.94 billion Indian Rupees [US$2.19 billion]
of which 101%
Dr.Reddy's Laboratories Ltd
(140.81 billion Indian Rupees [US$2.14 billion]
of which 82%
was Global Generics), and
(174.94 billion Indian Rupees [US$2.66 billion]
of which 100%
During the year ended March of 2017, sales at
Aurobindo Pharma Ltd were 149.10 billion Indian Rupees (US$2.27 billion).
increase of 7.3%
versus 2016, when the company's sales were 138.96 billion Indian Rupees.
This was the fifth consecutive year of sales increases at Aurobindo Pharma Ltd
(and since 2012, sales have increased a total of 228%).